Jyong Biotech Ltd. Ordinary Shares (MENS) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -913K | -426 | -2.71M | -1.39K | -655 |
| Operating CF Margin % | - | - | - | - | - |
| Operating CF Growth % | -139395.8% | - | - | - | - |
| Net Income | -847 | -847 | -663 | -663 | -1.33K |
| Depreciation & Amortization | 29 | 29 | 31 | 31 | 31 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -912.35K | 229 | -2.71M | 152 | 172 |
| Working Capital Changes | 163 | 163 | -907 | -907 | 472 |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 848K | 424 | 1.14M | 571 | 658 |
| Debt Issued (Net) | 951K | 0 | 1.25M | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -103K | 424 | -110K | 571 | 658 |
| Net Change in Cash | 2K | 0 | 99K | 0 | 0 |
| Free Cash Flow | -426 | -426 | -1.39K | -1.39K | -655 |
| FCF Margin % | - | - | - | - | - |
| FCF Growth % | 34.99% | - | - | - | - |
| FCF per Share | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 |
| FCF Conversion (FCF/Net Income) | 1078.56x | 0.50x | 4088.99x | 2.09x | 0.49x |
| Interest Paid | 57 | 57 | 55 | 55 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 |